微小RNA-203通过靶向胸苷酸合成酶增强结直肠癌对5-氟尿嘧啶的化疗敏感性。

miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.

作者信息

Li Tao, Gao Feng, Zhang Xi-Peng

机构信息

Colorectal Center, Tianjin Union Medical Center, Tianjin 300121, P.R. China.

Department of General Surgery, Qingdao Hiser Medical Center, Qingdao, Shandong 266033, P.R. China.

出版信息

Oncol Rep. 2015 Feb;33(2):607-14. doi: 10.3892/or.2014.3646. Epub 2014 Dec 4.

Abstract

MicroRNAs (miRNAs) are a conserved class of small non-coding RNAs that play important roles in diverse biological processes, including chemoresistance. However, the molecular mechanism as to how miR-203 modulates the chemosensitivity to 5-fluorouracil (5-FU) in colorectal cancer is poorly known. In the present study, we found that miR-203 was downregulated in the 5-FU-resistant cell line LoVo/5-Fu, and was inversely correlated with the extent of 5-FU chemoresistance. Cytotoxicity assay showed that the inhibition of miR-203 expression enhanced 5-FU chemoresistance in colorectal cancer cells, while miR-203 overexpression increased 5-FU chemosensitivity. We then validated that thymidylate synthase (TYMS) was a direct target of miR-203 and miR-203 suppressed TYMS protein levels. Silencing of TYMS enhanced 5-FU chemosensitivity, similar to the roles of miR-203. Finally, we discovered that miR-203 increased the inhibitory effects of 5-FU on tumor growth in vivo. Overall, our data indicate that miR-203 enhances 5-FU chemosensitivity via the downregulation of TYMS in colorectal cancer and provide important insight into the mechanism of 5-FU resistance in colorectal cancer patients. More important, the present study suggests that miR-203 has the potential as a therapeutic strategy for 5-FU-resistant colorectal cancer.

摘要

微小RNA(miRNA)是一类保守的小非编码RNA,在包括化疗耐药性在内的多种生物学过程中发挥重要作用。然而,关于miR-203如何调节结直肠癌对5-氟尿嘧啶(5-FU)的化疗敏感性的分子机制尚不清楚。在本研究中,我们发现miR-203在5-FU耐药细胞系LoVo/5-Fu中表达下调,且与5-FU化疗耐药程度呈负相关。细胞毒性试验表明,抑制miR-203表达可增强结直肠癌细胞对5-FU的化疗耐药性,而miR-203过表达则增加5-FU化疗敏感性。随后我们验证胸苷酸合成酶(TYMS)是miR-203的直接靶点,miR-203可抑制TYMS蛋白水平。沉默TYMS可增强5-FU化疗敏感性,与miR-203的作用相似。最后,我们发现miR-203可增强5-FU对体内肿瘤生长的抑制作用。总体而言,我们的数据表明,miR-203通过下调结直肠癌中的TYMS增强5-FU化疗敏感性,并为结直肠癌患者5-FU耐药机制提供了重要见解。更重要的是,本研究表明miR-203有潜力作为5-FU耐药结直肠癌的一种治疗策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索